...osteoporosis in postmenopausal women. Asahi Kasei Pharma Corp. (Tokyo, Japan) markets teriparatide in Japan as Teribone...

...Asahi launched Teribone teriparatide in Japan to treat osteoporosis in patients with a high risk of...
...use Zosano's ZP Patch microprojection delivery technology to develop and commercialize a transdermal formulation of Teribone...

...delivery technology to develop and commercialize a transdermal formulation of Asahi's once-weekly subcutaneous osteoporosis drug Teribone...

...delivery technology to develop and commercialize a transdermal formulation of Asahi's once-weekly subcutaneous osteoporosis drug Teribone...